Sign Up Today and Learn More About AOBiome Stock
Invest in or calculate the value of your shares in AOBiome or other pre-IPO companies through EquityZen's platform.
About AOBiome Stock
Founded
2013
Headquarters
Cambridge, MA, US
Total Funding
38.7M
Industries
Software, Artificial Intelligence, Data and Analytics
AOBiome is a life sciences company that focuses on transforming human health by developing microbiome-based therapies for inflammatory conditions. The company's portfolio includes multiple clinical-stage programs; a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study to treat patients with adult eczema (atopic dermatitis), a Phase 2 study for the prevention of episodic migraines, and a Phase 1b/2a clinical trial for the treatment of allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications. Its product candidates harness a single strain of class-defining, auto-regulating Ammonia Oxidizing Bacteria (AOB), a human commensal, enabling healthcare practitioners to produce well-understood and well-characterized biochemical compound that are critical to human health. AOBiome was founded in 2013 and is headquartered in Cambridge, Massachusetts.
AOBiome Press Mentions
Stay in the know about the latest news on AOBiome
Global Fecal Microbiota Transplantation FMT Market Set For 7.0% Growth, Reaching $1.12 Billion By 2028
einpresswire • Dec 09, 2024
Topical use and delivery of ammonia oxidizing microorganisms
patents • Apr 13, 2024
Ammonia oxidizing microorganisms for the treatment of diaper rash, athlete’s …
patents • Apr 13, 2024
Ammonia oxidizing microorganisms for the treatment of pulmonary hypertension
patents • Apr 13, 2024
Ammonia oxidizing microorganisms for use and delivery in built environments
patents • Apr 13, 2024
Investors in AOBiome
Discover investors in AOBiome stock and explore their portfolio companies
AOBiome Management
Leadership team at AOBiome
Chief Executive Officer
Todd Krueger
Join now and verify your accreditation status to gain access to:
- AOBiome current valuation
- AOBiome stock price
- Available deals in AOBiome and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading AOBiome Stock
How to invest in AOBiome stock?
Accredited investors can buy pre-IPO stock in companies like AOBiome through EquityZen funds. These investments are made available by existing AOBiome shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell AOBiome stock?
Shareholders can sell their AOBiome stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
